Yassine Zaïr - Concepedia

Concepedia

Author

Yassine Zaïr

Also Known As

Y Zair, Y Zaïr, Y Zaı̈r, Y. Zair, Y. Zaïr, Yassine Zair, Yassine Zaïr, Yassine Zaïr, Yassine Zäir, Zair, Yassine

53

Publications

1.9K

Citations

24

H-Index

46

Concepts

All Affiliations

Inserm Centre de Recherche en Nutrition Humaine Rhône-Alpes Institut du Thorax Nantes Université Centre Hospitalier Universitaire de Nantes

YZ

About

Yassine Zaïr is an author at Inserm specializing in medicine, atherosclerosis, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	315
2	Health Sciences	5	5	169
3	Public Health	2	2	42
4	Biochemistry	2	2	75
5	Clinical Nutrition	1	1	11

Yassine Zaïr

×

32

Publications

1.9K

Citations

24

H-Index

	Year	Citations
Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects Bertrand Cariou, Rémy Hanf, S. Lambert-Porcheron, Diabetes Care	2013	205
Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in<i>PCSK9</i> Khadija Ouguerram, Maud Chétiveaux, Yassine Zaïr, Arteriosclerosis Thrombosis and Vascular Biology	2004	180
Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism Bertrand Cariou, Yassine Zaïr, Bart Staels, Diabetes Care	2011	163
PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia Bertrand Cariou, Khadija Ouguerram, Yassine Zaïr, Arteriosclerosis Thrombosis and Vascular Biology	2009	136
Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults Bertrand Cariou, Maud Chétiveaux, Yassine Zaïr, Nutrition & Metabolism	2011	116
Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets Bertrand Cariou, Cédric Langhi, M. Le Bras, Nutrition & Metabolism	2013	110
Characterization of Autosomal Dominant Hypercholesterolemia Caused by <i>PCSK9</i> Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody Paul N. Hopkins, Joep C. Defesche, Sigrid W. Fouchier, Circulation Cardiovascular Genetics	2015	109
Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells Florent Lalanne, Gilles Lambert, Marcelo Amar, Journal of Lipid Research	2005	100
Dual Mechanisms for the Fibrate-mediated Repression of Proprotein Convertase Subtilisin/Kexin Type 9 Sanae Kourimate, Cédric Le May, Cédric Langhi, Journal of Biological Chemistry	2008	91
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects Véronique Ferchaud‐Roucher, Etienne Pouteau, Hugues Piloquet, American Journal of Physiology-Endocrinology and Metabolism NutritionGastroenterologyGlycerol TurnoverDietary FibrePlasma Acetate Turnover	2005	54

Page 1